Mymetics Corp Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | 430K 467K 38.91M | Sales 2022 | 1.03M 1.12M 93.03M | Capitalization | 8.51M 9.24M 771M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.34M -362M | Net income 2022 | -4M -4.34M -362M | EV / Sales 2021 | 177 x |
Net Debt 2021 | 67.1M 72.85M 6.07B | Net Debt 2022 | 71.68M 77.82M 6.49B | EV / Sales 2022 | 78 x |
P/E ratio 2021 |
-1.86
x | P/E ratio 2022 |
-1.77
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/09/01 | |
Mario Amacker
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Staehelin
BRD | Director/Board Member | 76 | 02/07/02 |
Ulrich Burkhard
BRD | Director/Board Member | 63 | 23/12/23 |
Marcel B. Rüegg
BRD | Director/Board Member | - | 16/23/16 |
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |